These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 17384652)
1. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray. Li SH; Li CF; Sung MT; Eng HL; Hsiung CY; Huang WW; Lin CN; Yu SC; Huang HY Mod Pathol; 2007 Apr; 20(4):497-507. PubMed ID: 17384652 [TBL] [Abstract][Full Text] [Related]
2. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
3. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of p27(Kip1) -interacting cell-cycle regulators in the adult testicular germ cell tumors: potential role in tumor development and histological progression. Miyai K; Yamamoto S; Iwaya K; Asano T; Tamai S; Tsuda H; Matsubara O APMIS; 2012 Nov; 120(11):890-900. PubMed ID: 23009113 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z; Fu Q; Lv J; Wang F; Ding K J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157 [TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O Virchows Arch; 2009 Nov; 455(5):413-22. PubMed ID: 19855998 [TBL] [Abstract][Full Text] [Related]
8. Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma. Yamamoto S; Tsuda H; Miyai K; Takano M; Tamai S; Matsubara O Histopathology; 2010 May; 56(6):740-9. PubMed ID: 20546339 [TBL] [Abstract][Full Text] [Related]
9. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Hao B; Zheng N; Schulman BA; Wu G; Miller JJ; Pagano M; Pavletich NP Mol Cell; 2005 Oct; 20(1):9-19. PubMed ID: 16209941 [TBL] [Abstract][Full Text] [Related]
10. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Bhatt KV; Hu R; Spofford LS; Aplin AE Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847 [TBL] [Abstract][Full Text] [Related]
12. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743 [TBL] [Abstract][Full Text] [Related]
13. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Old JB; Kratzat S; Hoellein A; Graf S; Nilsson JA; Nilsson L; Nakayama KI; Peschel C; Cleveland JL; Keller UB Mol Cancer Res; 2010 Mar; 8(3):353-62. PubMed ID: 20197382 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Lin R; Wang TT; Miller WH; White JH Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749 [TBL] [Abstract][Full Text] [Related]
15. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas. Shintani S; Li C; Mihara M; Hino S; Nakashiro K; Hamakawa H Oncology; 2003; 65(4):355-62. PubMed ID: 14707456 [TBL] [Abstract][Full Text] [Related]
16. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732 [TBL] [Abstract][Full Text] [Related]
17. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression. Hoellein A; Graf S; Bassermann F; Schoeffmann S; Platz U; Hölzlwimmer G; Kröger M; Peschel C; Oostendorp R; Quintanilla-Fend L; Keller U Mol Cell Biol; 2012 Jul; 32(13):2416-27. PubMed ID: 22508990 [TBL] [Abstract][Full Text] [Related]